Xenon and nitrous oxide do not depress cardiac function in an isolated rat heart model

Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie
Harumi NakayamaHidenori Toyooka

Abstract

To examine the inotropic and chronotropic effects of xenon (Xe) and nitrous oxide (N2O) compared with nitrogen (N2) on isolated rat hearts. The differences between Xe and N2O were also compared. The effects of Xe, N2O and N2 on coronary perfusion pressure (CPP), heart rate, left ventricular developed pressure (LVDP) and double product (DP) were examined in isolated rat hearts perfused at constant flow (10 mL x min(-1)). Following stabilization and baseline measurement with 95% O2 (plus 5% CO2), the heart was exposed to buffer equilibrated with one of three test gases; 50% N2 with 45% O2 (Group N2: n=9), 50% Xe with 45% O2 (Group Xe: n=9), or 50% N2O with 45% O2 (Group N2O: n=9) for 30 min. Measurements were performed in the last minute of exposure to the test gases. Gas exposure in all three groups decreased O2 delivery (-50%), CPP (-11%), LVDP (-30%) and DP (-44%) compared with baseline values (P <0.001). However, there were no differences among the groups. Our data suggest that cardiac contractility was decreased by the effects of reduced O2 delivery, but both Xe and N2O did not cause further cardiac depressant effects compared to N2 in this experimental model.

References

Feb 1, 1992·Anaesthesia and Intensive Care·R R KennedyP Downing
Mar 1, 1973·British Journal of Anaesthesia·A StewardW W Mapleson
Nov 1, 1972·Anesthesia and Analgesia·J H Eisele, N T Smith
Feb 1, 1980·Anesthesia and Analgesia·R KawamuraL R Webster
May 29, 1998·British Journal of Anaesthesia·T GotoS Morita
Mar 17, 2000·Anesthesiology·C LynchR Tenbrinck

❮ Previous
Next ❯

Citations

Apr 3, 2002·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Takahisa Goto
Jul 15, 2005·Best Practice & Research. Clinical Anaesthesiology·Benedikt Preckel, Wolfgang Schlack
Jul 15, 2005·Best Practice & Research. Clinical Anaesthesiology·U R Jahn, E Berendes
Jun 16, 2005·Acta Anaesthesiologica Scandinavica·J-H BaumertR Rossaint
Jul 20, 2005·Journal of Magnetic Resonance Imaging : JMRI·Isabelle IltisMonique Bernard
Mar 3, 2007·British Journal of Hospital Medicine·N Baskar, J D Hunter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.